Bioextrax AB (publ) (BIOEX.ST) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-110.7%

-SEK 0.25

vs SEK 2.36 price

Levered DCF

-SEK 0.84

After debt service

Piotroski score

0 / 9

Weak

Altman Z-score

23.33

Safe zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-6.22×	-7×	-3.56×	-3.1×	-90.31×	-179.31×	-24.6×	-55.24×
P/B	5.23×	4.66×	3.72×	1.83×	126.12×	605.23×	39.81×	166.27×
P/S	146.53×	235.6×	37.15×	147.08×	3,429.69×	45,961.54×	0×	0×
EV / EBITDA	-6.21×	-6.43×	-3.05×	-1.68×	-92.03×	-185.09×	-25.83×	-55.7×
Gross margin	-2170.0%	-177.7%	34.9%	-4718.2%	-4092.5%	-26386.7%	0.0%	0.0%
Operating margin	-2426.4%	-3405.6%	-1050.5%	-5220.0%	-4092.5%	-26386.7%	0.0%	0.0%
Net margin	-2338.8%	-3366.6%	-1046.1%	-4725.8%	-3819.2%	-25586.1%	0.0%	0.0%
Current ratio	1.58×	6.54×	7.46×	4.94×	2.22×	1.77×	2.21×	1.12×
Debt / equity	0×	0×	0×	0×	0×	0×	0×	0×
Interest coverage	-18,368×	-8,769.5×	0×	0×	-3,761.82×	-2,021.09×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-83.5%	-66.5%	-104.7%	-58.8%	-140.4%	-336.9%	-161.4%	-300.8%
Return on invested capital	-86.6%	-76.0%	-105.2%	-64.9%	-150.5%	-347.5%	-273.6%	-533.9%
Return on assets	-71.6%	-59.8%	-95.5%	-49.2%	-83.3%	-183.6%	-114.4%	-51.6%
Free cash flow yield	-23.6%	-15.7%	-32.0%	-42.0%	-1.0%	-0.4%	-7.7%	0.8%
Earnings yield	-16.0%	-14.3%	-28.2%	-32.1%	-1.1%	-0.6%	-4.1%	-1.8%
Enterprise value	SEK 107M	SEK 104.1M	SEK 63M	SEK 30.6M	SEK 936.8M	SEK 998.8M	SEK 48.5M	SEK 47.6M
Net debt / EBITDA	0.23×	1.07×	0.65×	1.51×	0.88×	0.38×	0.31×	1.69×
Cash conversion cycle (days)	752	556	-237	-68	-70	-10	-372	-11